COMPARISON OF SYSTEMIC AND LOCAL APPLICATION OF TRANEXAMIC ACID ON BLEEDING AND BLOOD TRANSFUSION NEED IN PATIENTS UNDERGOING CORONARY ARTERY BYPASS
DOI:
https://doi.org/10.32461/2226-3209.3.2018.178839Анотація
Abstract: Comparison of the effect of systemic administration and transamine position on bleeding and the need for blood transfusion in patients undergoing coronary artery bypass surgery, goals, comparing the amount of bleeding and blood transfusion in 48 hours after surgery, design by random sampling by blocking, 180 patients will enter this study, How to do after seeking consent, 60 patients will be assigned to the systemic intervention group and 60 patients will be assigned to the intervention group and 60 patients will be in the control group. Entry requirements: All patients undergoing coronary artery bypass graft surgery for the first time. Exclusion criteria in patients with renal failure, anemic patients, patients with low cardiac output, patients with coagulation disorder, and intervention; patients undergoing anesthesia induction of 10 mg / kg of body weight within the regimen Receive a dose of 1 mg of the drug per kg body weight per surgical hour until the end of surgery, after the surgery. In the local group, 1 g of the transamine solution was dissolved in 100 ml of chloride. 0.9% at the end of the surgery in the pericardial cavity of the heart. 60 patients will not receive the drug control group, all of the surgery will be performed by two surgeons under the same anesthetic and bypass procedure, the main outcome of the cerebral hemorrhage 6, 12, 24, 48 hours after surgery, and the rate of blood transfusion in 48 hours. From surgery.
Key word: Local Tranexamic acid, systemic tranexamic acid, coronary artery bypass surgery, bleeding, blood transfusion
Посилання
Abrishami A, Chung F, Wong J. Topical application of antifibrinolytic drugs for on-pump cardiac surgery: a
systematic review and meta-analysis. Canadian Journal of Anesthesia/Journal canadien d'anesthésie. 2009;56(3):202-
Kevy SV, Glickman RM, Bernhard WF, Diamond LK, Gross RE. The pathogenesis and control of the
hemorrhagic defect in open heart surgery. Surgery, gynecology & obstetrics. 1966;123(2):313-8.
Khalil PN, Ismail M, Kalmar P, von Knobelsdorff G, Marx G. Activation of fibrinolysis in the pericardial
cavity after cardiopulmonary bypass. Thrombosis and haemostasis. 2004;91(03):568-74.
Lemmer JH, Stanford W, Bonney SL, Breen JF, Chomka EV, Eldredge WJ, et al. Aprotinin for coronary
bypass operations: efficacy, safety, and influence on early saphenous vein graft patency. The Journal of thoracic and
cardiovascular surgery. 1994;107(2):543-53.
Spegar J, Vanek T, Snircova J, Fajt R, Straka Z, Pazderkova P, et al. Local and systemic application of
tranexamic acid in heart valve surgery: a prospective, randomized, double blind LOST study. Journal of thrombosis and
thrombolysis. 2011;32(3):303-10.
Ngaage DL, Bland JM. Lessons from aprotinin: is the routine use and inconsistent dosing of tranexamic acid
prudent? Meta-analysis of randomised and large matched observational studies☆. European Journal of Cardio-thoracic
surgery. 2010;37(6):1375-83.
Grassin-Delyle S, Couturier R, Abe E, Alvarez JC, Devillier P, Urien S. A practical tranexamic acid dosing
scheme based on population pharmacokinetics in children undergoing cardiac surgery. Anesthesiology: The Journal of
the American Society of Anesthesiologists. 2013;118(4):853-62.
Henry D, Carless P, Fergusson D, Laupacis A. The safety of aprotinin and lysine-derived antifibrinolytic drugs
in cardiac surgery: a meta-analysis. Canadian Medical Association Journal. 2009;180(2):183-93.
De Bonis M, Cavaliere F, Alessandrini F, Lapenna E, Santarelli F, Moscato U, et al. Topical use of tranexamic
acid in coronary artery bypass operations: a double-blind, prospective, randomized, placebo-controlled study. The
Journal of Thoracic and Cardiovascular Surgery. 2000;119(3):575-80.
Jansen A, Andreica S, Claeys M, D'haese J, Camu F, Jochmans K. Use of tranexamic acid for an effective
blood conservation strategy after total knee arthroplasty. British journal of anaesthesia. 1999;83(4):596-601.
Kojima T, Gando S, Morimoto Y, Mashio H, Goda Y, Kawahigashi H, et al. Systematic elucidation of effects
of tranexamic acid on fibrinolysis and bleeding during and after cardiopulmonary bypass surgery. Thrombosis research.
;104(5):301-7.
Santos A, Kalil R, Bauemann C, Pereira J, Nesralla I. A randomized, double-blind, and placebo-controlled
study with tranexamic acid of bleeding and fibrinolytic activity after primary coronary artery bypass grafting. Brazilian
journal of medical and biological research. 2006;39(1):63-9.
Jimenez JJ, Iribarren JL, Lorente L, Rodriguez JM, Hernandez D, Nassar I, et al. Tranexamic acid attenuates
inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: a case control study
followed by a randomized double-blind controlled trial. Critical Care. 2007;11(6):R117.
Casati V, Della Valle P, Benussi S, Franco A, Gerli C, Baili P, et al. Effects of tranexamic acid on
postoperative bleeding and related hematochemical variables in coronary surgery: comparison between on-pump and
off-pump techniques. The Journal of thoracic and cardiovascular surgery. 2004;128(1):83-91.
Weber CF, Görlinger K, Byhahn C, Moritz A, Hanke AA, Zacharowski K, et al. Tranexamic acid partially
improves platelet function in patients treated with dual antiplatelet therapy. European Journal of Anaesthesiology
(EJA). 2011;28(1):57-62.
Sigaut S, Tremey B, Ouattara A, Couturier R, Taberlet C, Grassin-Delyle S, et al. Comparison of two doses of
tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass. The Journal of the American
Society of Anesthesiologists. 2014;120(3):590-600.
Shore-Lesserson L, Reich DL, Vela-Cantos F, Ammar T, Ergin MA. Tranexamic acid reduces transfusions and
mediastinal drainage in repeat cardiac surgery. Anesthesia & Analgesia. 1996;83(1):18-26.
Kimenai DM, Gerritse BM, Lucas C, Rosseel PM, Bentala M, van Hattum P, et al. Effectiveness of pericardial
lavage with or without tranexamic acid in cardiac surgery patients receiving intravenous tranexamic acid: a randomized
controlled trial. European Journal of Cardio-Thoracic Surgery. 2016;50(6):1124-31.
Fawzy H, Elmistekawy E, Bonneau D, Latter D, Errett L. Can local application of Tranexamic acid reduce
post-coronary bypass surgery blood loss? A randomized controlled trial. Journal of cardiothoracic surgery.
;4(1):25.
Koster A, Börgermann J, Zittermann A, Lueth J, Gillis-Januszewski T, Schirmer U. Moderate dosage of
tranexamic acid during cardiac surgery with cardiopulmonary bypass and convulsive seizures: incidence and clinical
outcome. British journal of anaesthesia. 2012;110(1):34-40.
Manji RA, Grocott HP, Leake J, Ariano RE, Manji JS, Menkis AH, et al. Seizures following cardiac surgery:
the impact of tranexamic acid and other risk factors. Canadian Journal of Anesthesia/Journal canadien d'anesthésie.
;59(1):6-13.
Montes FR, Pardo DF, Carreño M, Arciniegas C, Dennis RJ, Umaña JP. Risk factors associated with
postoperative seizures in patients undergoing cardiac surgery who received tranexamic acid: a case-control study.
Annals of cardiac anaesthesia. 2012;15(1):6.
Taksaudom N, Siwachat S, Tantraworasin A. Additional effects of topical tranexamic acid in on-pump cardiac
surgery. Asian Cardiovascular and Thoracic Annals. 2017;25(1):24-30.
Hosseini H, Rahimianfar AA, Abdollahi MH, Moshtaghiyoon MH, Haddadzadeh M, Fekri A, et al.
Evaluations of topical application of tranexamic acid on post-operative blood loss in off-pump coronary artery bypass
surgery. Saudi journal of anaesthesia. 2014;8(2):224.
Emara WM, Moez KK, Elkhouly AH. Topical versus intravenous tranexamic acid as a blood conservation
intervention for reduction of post-operative bleeding in hemiarthroplasty. Anesthesia, essays and researches.
;8(1):48.
Verstraete M. Clinical application of inhibitors of fibrinolysis. Drugs. 1985;29(3):236-61.
Valsecchi A. Further notes on the topical use of tranexamic acid in the treatment of gynecological hemorrhage.
Minerva ginecologica. 1980;32(9):825.
Sindet-Pedersen S, Ramström G, Bernvil S, Blombäck M. Hemostatic effect of tranexamic acid mouthwash in
anticoagulant-treated patients undergoing oral surgery. New England Journal of Medicine. 1989;320(13):840-3.
Mahaffey R, Wang L, Hamilton A, Phelan R, Arellano R. A retrospective analysis of blood loss with
combined topical and intravenous tranexamic acid after coronary artery bypass graft surgery. Journal of cardiothoracic
and vascular anesthesia. 2013;27(1):18-22.
Kirklin JW, Kouchoukos NT. Kirklin/Barratt-Boyes Cardiac Surgery: Churchill Livingstone; 2012.
Paparella D, Brister SJ, Buchanan MR. Coagulation disorders of cardiopulmonary bypass: a review. Intensive
care medicine. 2004;30(10):1873-81.
Karthik S, Grayson AD, McCarron EE, Pullan DM, Desmond MJ. Reexploration for bleeding after coronary
artery bypass surgery: risk factors, outcomes, and the effect of time delay. The Annals of thoracic surgery.
;78(2):527-34.
Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD. Increased mortality, postoperative
morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation. 2007;116(22):2544-
Ferraris VA, Ferraris SP, Saha SP, Hessel EA, Haan CK, Royston BD, et al. Perioperative blood transfusion
and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular
Anesthesiologists clinical practice guideline. The Annals of thoracic surgery. 2007;83(5):S27-S86.
Horrow JC, Van Riper DF, Strong MD, Grunewald KE, Parmet JL. The dose-response relationship of
tranexamic acid. The Journal of the American Society of Anesthesiologists. 1995;82(2):383-92.
Lambert W, Brisebois FJ, Wharton TJ, Carrier RC, Boyle D, Rowe BH. The effectiveness of low dose
tranexamic acid in primary cardiac surgery. Canadian journal of anaesthesia. 1998;45(6):571-4.
Dowd NP, Karski JM, Cheng DC, Carroll JA, Lin Y, James RL, et al. Pharmacokinetics of tranexamic acid
during cardiopulmonary bypass. The Journal of the American Society of Anesthesiologists. 2002;97(2):390-9.
Baric D, Biocina B, Unic D, Sutlic Z, Rudez I, Vrca VB, et al. Topical use of antifibrinolytic agents reduces
postoperative bleeding: a double-blind, prospective, randomized study☆. European journal of cardio-thoracic surgery.
;31(3):366-71.
Vuylsteke A, Saravanan P, Gerrard C, Cafferty F. The impact of administration of tranexamic acid in reducing
the use of red blood cells and other blood products in cardiac surgery. BMC anesthesiology. 2006;6(1):9.
##submission.downloads##
Номер
Розділ
Ліцензія
Автори, які публікуються у цьому журналі, погоджуються з наступними умовами:
1. Автори залишають за собою право на авторство своєї роботи та передають журналу право першої публікації цієї роботи на умовах ліцензії Creative Commons Attribution License, котра дозволяє іншим особам вільно розповсюджувати опубліковану роботу з обов'язковим посиланням на авторів оригінальної роботи та першу публікацію роботи у цьому журналі.
2. Автори мають право укладати самостійні додаткові угоди щодо неексклюзивного розповсюдження роботи у тому вигляді, в якому вона була опублікована цим журналом (наприклад, розміщувати роботу в електронному сховищі установи або публікувати у складі монографії), за умови збереження посилання на першу публікацію роботи у цьому журналі.
3.Політика журналу дозволяє і заохочує розміщення авторами в мережі Інтернет (наприклад, у сховищах установ або на особистих веб-сайтах) рукопису роботи, як до подання цього рукопису до редакції, так і під час його редакційного опрацювання, оскільки це сприяє виникненню продуктивної наукової дискусії та позитивно позначається на оперативності та динаміці цитування опублікованої роботи.